Gemcitabine and Docetaxel in Patients With Relapsed or Refractory Metastatic Colorectal Adenocarcinoma

NCT01639131 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

6

Enrollment

OTHER

Sponsor class

Conditions

Metastatic Colorectal Adenocarcinoma

Interventions

DRUG: Gemcitabine
DRUG: Docetaxel
DRUG: Filgrastim or Pegfilgrastim

Sponsor

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins